These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 32499785)

  • 1. Myeloid Cell-Derived Arginase in Cancer Immune Response.
    Grzywa TM; Sosnowska A; Matryba P; Rydzynska Z; Jasinski M; Nowis D; Golab J
    Front Immunol; 2020; 11():938. PubMed ID: 32499785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
    Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
    J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.
    Raber P; Ochoa AC; Rodríguez PC
    Immunol Invest; 2012; 41(6-7):614-34. PubMed ID: 23017138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy.
    Martí i Líndez AA; Dunand-Sauthier I; Conti M; Gobet F; Núñez N; Hannich JT; Riezman H; Geiger R; Piersigilli A; Hahn K; Lemeille S; Becher B; De Smedt T; Hugues S; Reith W
    JCI Insight; 2019 Nov; 4(24):. PubMed ID: 31751318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity.
    Miret JJ; Kirschmeier P; Koyama S; Zhu M; Li YY; Naito Y; Wu M; Malladi VS; Huang W; Walker W; Palakurthi S; Dranoff G; Hammerman PS; Pecot CV; Wong KK; Akbay EA
    J Immunother Cancer; 2019 Feb; 7(1):32. PubMed ID: 30728077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.
    Rodríguez PC; Ochoa AC
    Immunol Rev; 2008 Apr; 222():180-91. PubMed ID: 18364002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression.
    Matos A; Carvalho M; Bicho M; Ribeiro R
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses.
    Rodriguez PC; Quiceno DG; Zabaleta J; Ortiz B; Zea AH; Piazuelo MB; Delgado A; Correa P; Brayer J; Sotomayor EM; Antonia S; Ochoa JB; Ochoa AC
    Cancer Res; 2004 Aug; 64(16):5839-49. PubMed ID: 15313928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment.
    Su X; Xu Y; Fox GC; Xiang J; Kwakwa KA; Davis JL; Belle JI; Lee WC; Wong WH; Fontana F; Hernandez-Aya LF; Kobayashi T; Tomasson HM; Su J; Bakewell SJ; Stewart SA; Egbulefu C; Karmakar P; Meyer MA; Veis DJ; DeNardo DG; Lanza GM; Achilefu S; Weilbaecher KN
    J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34520398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginase 1 is a key driver of immune suppression in pancreatic cancer.
    Menjivar RE; Nwosu ZC; Du W; Donahue KL; Hong HS; Espinoza C; Brown K; Velez-Delgado A; Yan W; Lima F; Bischoff A; Kadiyala P; Salas-Escabillas D; Crawford HC; Bednar F; Carpenter E; Zhang Y; Halbrook CJ; Lyssiotis CA; Pasca di Magliano M
    Elife; 2023 Feb; 12():. PubMed ID: 36727849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boronic acid-based arginase inhibitors in cancer immunotherapy.
    Borek B; Gajda T; Golebiowski A; Blaszczyk R
    Bioorg Med Chem; 2020 Sep; 28(18):115658. PubMed ID: 32828425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginase: an emerging key player in the mammalian immune system.
    Munder M
    Br J Pharmacol; 2009 Oct; 158(3):638-51. PubMed ID: 19764983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.
    Rodriguez PC; Ernstoff MS; Hernandez C; Atkins M; Zabaleta J; Sierra R; Ochoa AC
    Cancer Res; 2009 Feb; 69(4):1553-60. PubMed ID: 19201693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells.
    Obermajer N; Wong JL; Edwards RP; Odunsi K; Moysich K; Kalinski P
    Immunol Invest; 2012; 41(6-7):635-57. PubMed ID: 23017139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of trypanosomatid's arginase in polyamine biosynthesis and pathogenesis.
    Balaña-Fouce R; Calvo-Álvarez E; Álvarez-Velilla R; Prada CF; Pérez-Pertejo Y; Reguera RM
    Mol Biochem Parasitol; 2012 Feb; 181(2):85-93. PubMed ID: 22033378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells.
    Mondanelli G; Bianchi R; Pallotta MT; Orabona C; Albini E; Iacono A; Belladonna ML; Vacca C; Fallarino F; Macchiarulo A; Ugel S; Bronte V; Gevi F; Zolla L; Verhaar A; Peppelenbosch M; Mazza EMC; Bicciato S; Laouar Y; Santambrogio L; Puccetti P; Volpi C; Grohmann U
    Immunity; 2017 Feb; 46(2):233-244. PubMed ID: 28214225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion.
    Zea AH; Rodriguez PC; Atkins MB; Hernandez C; Signoretti S; Zabaleta J; McDermott D; Quiceno D; Youmans A; O'Neill A; Mier J; Ochoa AC
    Cancer Res; 2005 Apr; 65(8):3044-8. PubMed ID: 15833831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-derived suppressor cells reveal radioprotective properties through arginase-induced l-arginine depletion.
    Leonard W; Dufait I; Schwarze JK; Law K; Engels B; Jiang H; Van den Berge D; Gevaert T; Storme G; Verovski V; Breckpot K; De Ridder M
    Radiother Oncol; 2016 May; 119(2):291-9. PubMed ID: 26874542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of immune responses by L-arginine metabolism.
    Bronte V; Zanovello P
    Nat Rev Immunol; 2005 Aug; 5(8):641-54. PubMed ID: 16056256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade.
    Aaboe Jørgensen M; Ugel S; Linder Hübbe M; Carretta M; Perez-Penco M; Weis-Banke SE; Martinenaite E; Kopp K; Chapellier M; Adamo A; De Sanctis F; Frusteri C; Iezzi M; Zocca MB; Hargbøll Madsen D; Wakatsuki Pedersen A; Bronte V; Andersen MH
    Cancer Immunol Res; 2021 Nov; 9(11):1316-1326. PubMed ID: 34518197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.